GEODE CAPITAL MANAGEMENT, LLC
Position in OBIO — Orchestra BioMed Holdings, Inc.
CIK 1214717
BOSTON, MA
Position in OBIO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,349,122
+$2,285,782 QoQ
Shares Held
1,007,908
+107.6% QoQ
Ownership
1.68%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 77 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. OBIO ranks #256 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in OBIO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,349,122 | 1,007,908 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,063,340 | 485,492 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,964,456 | 473,363 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $959,261 | 386,799 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $809,579 | 302,082 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,548,448 | 595,432 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,289,764 | 572,441 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,915,504 | 567,219 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,533,168 | 556,217 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,319,316 | 440,098 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,887,088 | 425,749 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,624,947 | 415,705 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,363,292 | 194,756 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,446,367 | 125,006 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 HSAQ | — | 12,421 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 HSAQ | — | 12,421 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 HSAQ | — | 12,421 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 HSAQ | — | 12,421 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 HSAQ | — | 12,421 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 HSAQ | — | 10,388 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 HSAQ | — | 10,388 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||